Omudhome Ogbru, PharmD
Omudhome Ogbru, PharmD
Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
GENERIC NAME: altretamine
BRAND NAME: Hexalen
DRUG CLASS AND MECHANISM: Altretamine is an oral drug that is used to treat ovarian cancer. The precise mechanism by which altretamine exerts its anti-cancer effect is unknown. It was approved by the FDA in 1990.
GENERIC AVAILABLE: No.
PREPARATIONS: Capsules of 50 mg.
STORAGE: Capsules should be stored at room temperature, 15 C to 30 C (59 F to 86 F).
PRESCRIBED FOR: Altretamine is used for the treatment of ovarian cancer that has persisted or has recurred following treatment with other anti-cancer drugs. Although not an approved use, altretamine also has been used for treating lung cancer.
DOSING: The dose of altretamine is 260 mg/square meter/day. Altretamine may be taken either for 14 or 21 consecutive days as part of one or more 28 day cycles. The total daily dose generally is split into four oral doses, one oral dose after each meal and at bedtime.
DRUG INTERACTIONS: Altretamine, when given to patients receiving antidepressants of the monoamine oxidase (MAO) inhibitor class (for example, phenelzine, tranylcypromine, linezolid) may cause severe orthostatic hypotension (a sudden drop in blood pressure upon standing). Combining altretamine with amitriptyline (Elavil, Endep), desipramine (Norpramin), imipramine (Tofranil, Tofranil-PM), or nortriptyline (Pamelor, Aventyl) also may increase the occurrence of orthostatic hypotension. Cimetidine (Tagamet) may reduce the elimination of altretamine from the body, increasing its blood levels and the risk of side effects. Pyridoxine (vitamin B6) may reduce the risk of neurotoxicity (see below) but may also reverse the beneficial affect of altretamine in the treatment of ovarian cancer.
PREGNANCY: Altretamine should not be used by pregnant women because it may harm the fetus.
NURSING MOTHERS: It is not known whether altretamine is secreted in human milk. Since altretamine may be toxic to nursing infants, breastfeeding is not recommended during treatment with altretamine.
SIDE EFFECTS: Nausea and vomiting of gradual onset occur frequently with altretamine. Peripheral neuropathy (abnormal function of the sensory nerves of the arms and legs giving rise to symptoms such as numbness, tingling, etc.) and central nervous system symptoms (mood disorders, disorders of consciousness, ataxia, dizziness, vertigo) have been reported; these effects appear to be reversible. White blood cell counts and platelet counts may drop with altretamine treatment, increasing the risk of infection and bleeding, respectively.
Reference: FDA Prescribing Information
Last Editorial Review: 3/19/2013
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Back to Medications Index